New Oncology Workflow with Advanced Toolset can Help Improve Reading, Reporting for Cancer Patients

CarestreamCarestream now offers an oncology reading workflow for PET/CT studies that equips clinicians with new native tools for its enterprise image management system that deliver both quantitative and qualitative information to help improve and expedite the reading process.

"The latest upgrade for our enterprise image management platform incorporates advanced tools to aid in tumor detection and tracking. This can help radiologists deliver more meaningful reports while also enhancing collaboration with clinicians and patients," said Ron Muscosky, Carestream’s Worldwide Clinical Solutions Product Line Manager.

"Traditional oncology features cannot adequately address the increased demand we can expect for long-term monitoring of oncology patients as the world's population ages. And the recent announcement of Medicare payments for CT lung cancer screening can be expected to boost imaging volumes for current and former smokers," he adds.

Carestream's new CT Perfusion and Subtraction modules contains interactive tools to ease the process of analyzing and comparing three-dimensional (3D), CT perfusion (CTP) and digital subtraction angiography (DSA) images. This equips users to analyze CT brain perfusion scans for tissue perfusion and tissue blood volume, while X-ray angiography (XA) subtraction capabilities provide a DSA workflow for analysis of vessel blockages in areas with bony or dense soft tissue.

"Carestream's new CT perfusion module that is native to the PACS demonstrated better coherence and consistency of perfusion maps and results and was easy to use," said Dr. Daniel Reizine, Radiologist, Department of Neuroradiology, Hospital Lariboisière (Paris, France).

Carestream also developed PET segmentation that allows users to examine tumor standardized uptake values (SUV) traces on the PET image without the need for a physical trace on a CT exam. This capability can play an important role in detection of early stage cancers.

The company's streamlined oncology reading workflow includes:

  • Automatic fusion of PET, SPECT, CT and MR images
  • Automatic registration between volumetric datasets that provide efficient comparison of multiple time points
  • Synchronized manipulations, color maps, measurement tools and pre-defined layouts that aid in analysis
  • Reproducible 2D and volumetric lesion segmentation and automated comparison to observe progression over time
  • Threshold segmentation, spheroid region of interest (ROI), metabolic tumor volume (MTV) and total lesion glycolysis (TLG)
  • Bookmarks to catalog lesions and speed future access and
  • Precise follow-up data for enhanced patient care.

An efficient reading workflow is supported by use of Carestream’s native Vue Reporting module that can present interactive hyperlinks to critical images and automatic inclusion of quantitative analysis in the form of easy-to-understand comparison tables and charts, which oncologists and referring physicians prefer.

Vue Reporting also offers bookmarks and lesion management reporting in accordance with international standards such as response evaluation criteria in solid tumors (RECIST). Reports and images can be shared using Carestream’s Vue Motion universal viewer that supports viewing on FDA-approved mobile devices.

Related news articles:

About Carestream Health
Carestream is a worldwide provider of dental and medical imaging systems and IT solutions; X-ray imaging systems for non-destructive testing; and advanced materials for the precision films and electronics markets - all backed by a global service and support network.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...